Thermo Fisher Scientific Inc.
TMO | NYSE
$686.04
-$10.96 (-1.57%)
Nov 2, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 32.61 | 31.38 | 34.18 | 31.06 | 34.03 | 28.93 |
PEG Ratio | 4.54 | 4.64 | -2.75 | -3.24 | 1.56 | 0.39 |
PS Ratio | 4.89 | 4.63 | 4.78 | 4.81 | 6.70 | 5.73 |
PB Ratio | 4.08 | 4.01 | 4.38 | 4.91 | 6.44 | 5.35 |
P/FCF Ratio | 34.62 | 27.35 | 29.58 | 31.24 | 37.45 | 27.07 |
P/OCF Ratio | 27.87 | 22.93 | 24.37 | 23.58 | 27.55 | 22.25 |
OCF/S Ratio | 17.55 | 20.21 | 19.61 | 20.38 | 24.34 | 25.73 |
Debt / Equity Ratio | 0.74 | 0.66 | 0.78 | 0.82 | 0.89 | 0.65 |
Quick Ratio | 1.53 | 1.29 | 1.39 | 1.15 | 1.12 | 1.74 |
Current Ratio | 1.89 | 1.66 | 1.75 | 1.48 | 1.50 | 2.13 |
Asset Turnover | 0.40 | 0.44 | 0.43 | 0.46 | 0.41 | 0.47 |
Interest Coverage | 5.71 | 4.63 | 4.99 | 11.74 | 19.25 | 14.28 |
Return on Equity | 12.61% | 12.78% | 12.83% | 15.80% | 18.94% | 18.47% |
Return on Assets | 6.11% | 6.51% | 6.07% | 7.15% | 8.12% | 9.23% |
Return on Invested Capital | 7.60% | 8.03% | 8.02% | 9% | 10.68% | 11.32% |
Dividend Yield | 0.29% | 0.29% | 0.26% | 0.21% | 0.15% | 0.18% |
Payout Ratio | 9.44% | 9.20% | 8.72% | 6.55% | 5.11% | 5.29% |
FCF Payout Ratio | 10.63% | 8.37% | 7.87% | 6.89% | 5.82% | 5.09% |
Gross Profit Margin | 40.93% | 41.34% | 40.12% | 42.33% | 50.07% | 49.75% |
Net Profit Margin | 15.12% | 14.77% | 13.99% | 15.47% | 19.70% | 19.79% |
Pretax Profit Margin | 16.31% | 16.31% | 14.56% | 17.06% | 22.54% | 22.43% |
Operating Profit Margin | 18.20% | 17.87% | 17.37% | 18.98% | 26.31% | 24.51% |
FCF Margin | 14.12% | 16.95% | 16.16% | 15.39% | 17.90% | 21.15% |
EBITDA Margin | 25.73% | 27.52% | 26.12% | 26.59% | 30.52% | 31.37% |
Add to Watchlist
Select watchlists to add or remove TMO